SK bioscience’s $84.5 Million Equity Investment in Novavax

Milbank represented SK bioscience Co. Ltd. in the deal.SK bioscience announced that its board of directors decided to make an equity investment in Novavax, securing 6.5…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Pietro Martinoia

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here